Elemis Sold to PAI Partners in Strategic Skincare Shift
L’Occitane Group has sold the British skincare brand Elemis to private equity firm PAI Partners, aiming to accelerate US and digital growth while preserving the brand's heritage.

L’Occitane Group sold the British skincare brand Elemis to French private equity firm PAI Partners on November 4. The sale marks the next phase of development for Elemis after seven years under L’Occitane ownership, with the transaction price remaining undisclosed. The deal is expected to close in the first quarter of 2027, pending regulatory approvals.
L’Occitane acquired Elemis in 2019 for USD 900 million, its largest-ever purchase. Chairman and CEO Reinold Geiger stated the divestment reflects a disciplined portfolio decision focused on creating long-term value. He noted, "Elemis has played a special role in the history of our group." The move may signal broader restructuring for the international beauty and wellness retailer, which recently delisted from the Hong Kong Stock Exchange.
PAI Partners outlines growth strategy
PAI Partners plans to accelerate Elemis’ expansion in the United States and grow its digital business. The firm will prioritize extending the brand’s reach via digital channels and selected premium retail partners. Gaëlle d’Engremont and Colm O’Sullivan, partners at PAI, said the skin care market’s resilience is bolstered by heightened demand for sensorial, efficacious, and premiumized products. They expressed support for Elemis’ next phase of development.
The partners highlighted Elemis’ premium positioning, clinically proven performance, and strong digital engagement as key differentiators. PAI has committed to preserving the brand’s British identity while pursuing these growth avenues. The firm will work closely with the existing Elemis management team to reinforce its leadership in the UK market and explore expansion in other global regions.
Elemis' market position and performance
Under L’Occitane’s ownership, Elemis nearly doubled its net sales to more than USD 300 million. The brand’s performance is characterized by a significant shift toward the US market and online sales.
| Metric | Performance |
|---|---|
| Net Sales (FY2026) | > USD 300 million |
| US Market Share of Net Sales | ~50% |
| Online Sales Share | ~50% |
Elemis achieved years of double-digit annual growth in the US since 2015. Approximately half of its sales now come from online channels, including its direct-to-consumer platform and digital partners. The brand strengthened its commercial partnerships, retail network, and sustainability credentials during L’Occitane’s stewardship.
Brand heritage and future direction
Founded in London in 1989, Elemis is described as a distinctive British skincare brand with a loyal global following. CEO and co-founder Noella Gabriel said that over the past seven years, the brand built a compelling product proposition and a differentiated customer experience under L’Occitane’s support. Elemis is grateful for that support and is excited for its next chapter with PAI Partners.
The brand’s portfolio includes cleansers, serums, moisturizers, and specialist treatments, with its Pro-Collagen franchise at the center. Future priorities include continuing to invest in this core range and accelerating product innovation. Elemis plans to bring its products to more people while staying true to its heritage and values. This includes expanding the Pro-Collagen franchise into body care and marking the growth of its hero product, the Pro-Collagen Marine Cream, with a Formula 1-themed pop-up at Selfridges. The brand’s blend of advanced science, luxury, and wellness aligns with key global skincare trends.





